On May 1, 2025, Axon Enterprise, Inc. announced that it will restate its financial statements for the year ended December 31, 2024 and certain quarterly periods due to an error in the classification of $690 million convertible notes, impacting their presentation in the balance sheet. The restatement will not affect total assets, total liabilities, or stockholders' equity.